Abstract
BackgroundDrug-resistant tuberculosis (DR-TB) is a global public health emergency. In April 2017, the National Tuberculosis Programme (NTP) of Sierra Leone, a high TB burden country, began using WHO-approved second-line drugs...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
